Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tonkin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Vaccine|April 26, 2012
Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particlesDaniel R Tonkin, Alan Whitmore, Robert E Johnston, et al.
Vaccine|February 27, 2010
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationDaniel R Tonkin, Patricia Jorquera, Tracie Todd, et al.
The Journal of Experimental Medicine|July 1, 2004
Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable regionChristopher M Snyder, Katja Aviszus, Ryan A Heiser, et al.
Journal of Virology|June 6, 2014
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceSyed Muaz Khalil, Daniel R Tonkin, Andrew T Snead, et al.
Vaccine|June 3, 2014
A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse modelSyed Muaz Khalil, Daniel R Tonkin, Melissa D Mattocks, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Vaccine|April 26, 2012
Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particlesDaniel R Tonkin, Alan Whitmore, Robert E Johnston, et al.
Vaccine|February 27, 2010
Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunizationDaniel R Tonkin, Patricia Jorquera, Tracie Todd, et al.
The Journal of Experimental Medicine|July 1, 2004
Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable regionChristopher M Snyder, Katja Aviszus, Ryan A Heiser, et al.
Journal of Virology|June 6, 2014
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal miceSyed Muaz Khalil, Daniel R Tonkin, Andrew T Snead, et al.
Vaccine|June 3, 2014
A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse modelSyed Muaz Khalil, Daniel R Tonkin, Melissa D Mattocks, et al.
Pageof 2